CUSIP 64125C109COMNBIXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
717 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 12.83M | $1.82B | +124.4K | Added |
| 2 | Vanguard Group Inc | 9.70M | $1.38B | −6.3K | Reduced |
| 3 | Dodge & Cox | 5.51M | $781.21M | −48.6K | Reduced |
| 4 | Jpmorgan Chase & Co | 5.20M | $737.57M |
| Added |
| 5 | State Street Corp | 4.24M | $601.74M | −103.8K | Reduced |
| 6 | Aqr Capital Management LLC | 3.27M | $462.65M | +498.1K | Added |
| 7 | Renaissance Technologies LLC | 2.24M | $317.53M | −179.5K | Reduced |
| 8 | Geode Capital Management, LLC | 2.06M | $291.34M | +34.5K | Added |
| 9 | Wellington Management Group LLP | 1.74M | $247.43M | −67.2K | Reduced |
| 10 | Bellevue Group AG | 1.70M | $241.58M | −59.8K | Reduced |
See every fund holding Neurocrine Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders